KIR-based inhibitory CARs overcome CAR-NK cell trogocytosis-mediated fratricide and tumor escape
Ye Li(The University of Texas MD Anderson Cancer Center), Rafet Başar(The University of Texas MD Anderson Cancer Center), Guohui Wang(The University of Texas MD Anderson Cancer Center), Enli Liu(The University of Texas MD Anderson Cancer Center), Judy S. Moyes(The University of Texas MD Anderson Cancer Center), Li Li(The University of Texas MD Anderson Cancer Center), Lucila Nassif Kerbauy(The University of Texas MD Anderson Cancer Center), Nadima Uprety(The University of Texas MD Anderson Cancer Center), Mohsen Fathi(University of Houston), Ali Rezvan(University of Houston), Pinaki P. Banerjee(The University of Texas MD Anderson Cancer Center), Luis Muniz-Feliciano(The University of Texas MD Anderson Cancer Center), Tamara Laskowski(The University of Texas MD Anderson Cancer Center), Emily L. Ensley(The University of Texas MD Anderson Cancer Center), May Daher(The University of Texas MD Anderson Cancer Center), Mayra Shanley(The University of Texas MD Anderson Cancer Center), Mayela Carolina Mendt(The University of Texas MD Anderson Cancer Center), Sunil Acharya(The University of Texas MD Anderson Cancer Center), Bin Liu(The University of Texas MD Anderson Cancer Center), Alexander Biederstädt(The University of Texas MD Anderson Cancer Center), Hind Rafei(The University of Texas MD Anderson Cancer Center), Xingliang Guo(The University of Texas MD Anderson Cancer Center), Luciana Melo Garcia(The University of Texas MD Anderson Cancer Center), Paul Lin(The University of Texas MD Anderson Cancer Center), Sonny Ang(The University of Texas MD Anderson Cancer Center), David Marín(The University of Texas MD Anderson Cancer Center), Ken Chen(The University of Texas MD Anderson Cancer Center), Laura Bover(The University of Texas MD Anderson Cancer Center), Richard E. Champlin(The University of Texas MD Anderson Cancer Center), Navin Varadarajan(University of Houston), Elizabeth J. Shpall(The University of Texas MD Anderson Cancer Center), Katayoun Rezvani(The University of Texas MD Anderson Cancer Center)
Cited by 161Open Access